This grant is for the purpose of developing and validating affordable, user-friendly cancer technologies specifically for low- and middle-income countries (LMICs). The National Cancer Institute (NCI) initiative seeks proposals to adapt existing or emerging assays and device prototypes into low-cost solutions for cancer prevention, detection, diagnosis, and treatment in LMIC settings. Successful projects will demonstrate technical functionality and clinical performance, undergoing validation and improvements within these regions. Applicants must possess a working prototype and form multidisciplinary teams comprising expertise in engineering, oncology, global healthcare delivery, and business development. A critical focus of the design criteria includes affordability, cost-effectiveness, and usability at the point-of-need, ensuring practical implementation for global health.
Opportunity ID: 331637
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-030 |
| Funding Opportunity Title: | Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 19, 2021 |
| Last Updated Date: | Feb 19, 2021 |
| Original Closing Date for Applications: | Jun 02, 2021 |
| Current Closing Date for Applications: | Jun 02, 2021 |
| Archive Date: | Jul 08, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments County governments Native American tribal governments (Federally recognized) Independent school districts City or township governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs. Applicants should have a working assay or device prototype (not necessarily already capable of cancer applications). The U01 project includes studies to both adapt this technology as well as demonstrate technical functionality and clinical performance for use of the device or assay in specific LMIC settings by meeting objective performance milestones followed by improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed; therefore, all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must consider affordability and cost-effectiveness as well as usability at the point-of-need as part of their design criteria. This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-030.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00265565 | May 02, 2021 | Jun 02, 2021 | View |
Package 1
Mandatory forms
331637 RR_SF424_2_0-2.0.pdf
331637 PHS398_CoverPageSupplement_5_0-5.0.pdf
331637 RR_OtherProjectInfo_1_4-1.4.pdf
331637 PerformanceSite_2_0-2.0.pdf
331637 RR_KeyPersonExpanded_2_0-2.0.pdf
331637 PHS398_ResearchPlan_4_0-4.0.pdf
331637 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331637 RR_Budget_1_4-1.4.pdf
331637 RR_SubawardBudget30_1_4-1.4.pdf
331637 PHS398_ModularBudget_1_2-1.2.pdf
331637 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
